Similar articles

• Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.

  Hoskin PJ, Saunders MI, Dische S. Hoskin PJ, et al. Cancer. 1999 Oct 1;86(7):1322-8. Cancer. 1999. PMID: 10506720 Clinical Trial.
• Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?

  Hartmann KA, Van der Kleij AJ, Schneider CJ, Sminia P. Hartmann KA, et al. Radiat Res. 1997 Nov;148(5):523-5. Radiat Res. 1997. PMID: 9355875 No abstract available.
• Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.

  Brizel DM, Hage WD, Dodge RK, Munley MT, Piantadosi CA, Dewhirst MW. Brizel DM, et al. Radiat Res. 1997 Jun;147(6):715-20. Radiat Res. 1997. PMID: 9189170
• Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

  Saunders M, Dische S. Saunders M, et al. Br J Cancer Suppl. 1996 Jul;27:S271-8. Br J Cancer Suppl. 1996. PMID: 8763896 Free PMC article. Review.
• A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.

  Kjellen E, Joiner MC, Collier JM, Johns H, Rojas A. Kjellen E, et al. Radiother Oncol. 1991 Oct;22(2):81-91. doi: 10.1016/0167-8140(91)90002-x. Radiother Oncol. 1991. PMID: 1835542 Review.